High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi

Plasma Epstein‐Barr virus (EBV) DNA measurement has established prognostic utility in EBV‐driven lymphomas, where it serves as a circulating tumor DNA marker. The value of plasma EBV measurement may be amplified in sub‐Saharan Africa (SSA), where advanced imaging and molecular technologies for risk...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Montgomery, Nathan D., Randall, Cara, Painschab, Matthew, Seguin, Ryan, Kaimila, Bongani, Kasonkanji, Edwards, Zuze, Takondwa, Krysiak, Robert, Sanders, Marcia K., Elliott, Avian, Miller, Melissa B., Kampani, Coxcilly, Chimzimu, Fred, Mulenga, Maurice, Damania, Blossom, Tomoka, Tamiwe, Fedoriw, Yuri, Dittmer, Dirk P., Gopal, Satish
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6970037/
https://ncbi.nlm.nih.gov/pubmed/31782984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2710
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi